Ignite Creation Date:
2024-05-06 @ 6:44 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05765747
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-03-13
First Post:
2023-03-01
Brief Title:
Effectiveness of Yunnan Baiyao in Improving Fracture Pain
Sponsor:
Peking University Third Hospital
Organization:
Peking University Third Hospital
Study Overview
Official Title:
A Randomized Controlled Clinical Trial of Effectiveness of Yunnan Baiyao in Improving Fracture Pain
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This will be a randomized controlled non-inferiority designed clinical trial 56 qualified subjects will be selected and allocated 11 to Yunnan Baiyao group and celecoxib group Each subject will be treated for 2 weeks and observed for 12 weeks which will be lasted for 14 weeks during the whole trial Yunnan Baiyao group will be given 4 times a day 2 capsules each time after morning afternoon and evening meals and before going to bed One capsule of Baoxianzi will be provided for the first time to be taken at the same time with Yunnan Baiyao Capsule which will be given continuously for 2 weeks The celecoxib group will be given 1 capsule twice a day after breakfast and dinner for 2 weeks
Detailed Description:
his will be a randomized controlled non-inferiority designed clinical trial 56 qualified subjects will be selected and allocated 11 to Yunnan Baiyao group and celecoxib group Each subject will be treated for 2 weeks and observed for 12 weeks which will be lasted for 14 weeks during the whole trial Yunnan Baiyao group will be given 4 times a day 2 capsules each time after morning afternoon and evening meals and before going to bed One capsule of Baoxianzi will be provided for the first time to be taken at the same time with Yunnan Baiyao Capsule which will be given continuously for 2 weeks The celecoxib group will be given 1 capsule twice a day after breakfast and dinner for 2 weeks
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None